Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said it placed at number 151 on the Globe and Mail's Report on Business annual list of Canada’s top-growing companies.
The company placed 151st out of 425 companies, with a three-year growth rate of 322%.
"Valeo Pharma is proud to have been named one of Canada's fastest-growing companies by the Globe and Mail" Valeo Pharma CEO Steve Saviuk said in a statement.
''This ranking is a result of the dedication of all of Valeo's employees and reflects the value that our innovative product portfolio brings to improving healthcare for Canadian patients."
The Report on Business magazine launched Canada’s Top Growing Companies ranking in 2019 and companies have to complete an in-depth application process and fulfill certain requirements in order to be recognized.
"Canada's Top Growing Companies acknowledges the drive and ingenuity displayed by Canadian business," Dawn Calleja, Editor of Report on Business magazine, said.
Valeo Pharma is a fast-growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology and Hospital Specialty Products.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie